Clinical Trial Update: A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy [Phase 4]

View source ↗

Summary

Clinical trial update describing a Phase 4 study of pralatrexate in Asian patients with peripheral T-cell lymphoma after prior therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Pralatrexate (pralatrexate)

Snippet

Sponsor: Taiwan Mundipharma Pharmaceuticals Ltd. | Conditions: Peripheral T Cell Lymphoma, Progression, Disease | Phase 4 | Status: UNKNOWN